Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Fractyl Health Inc (NASDAQ: GUTS) closed at $0.9 down -3.60% from its previous closing price of $0.93. In other words, the price has decreased by -$3.60 from its previous closing price. On the day, 0.75 million shares were traded. GUTS stock price reached its highest trading level at $0.94 during the session, while it also had its lowest trading level at $0.88.
Ratios:
For a deeper understanding of Fractyl Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on August 28, 2025, initiated with a Buy rating and assigned the stock a target price of $3.60.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.Morgan Stanley initiated its Overweight rating on February 27, 2024, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 65442276 and an Enterprise Value of 84677056. For the stock, the TTM Price-to-Sale (P/S) ratio is 3248.21. Its current Enterprise Value per Revenue stands at 4981.003 whereas that against EBITDA is -0.857.
Stock Price History:
The Beta on a monthly basis for GUTS is 1.50, which has changed by -0.71246004 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.53, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -36.25%, while the 200-Day Moving Average is calculated to be -45.16%.
Shares Statistics:
For the past three months, GUTS has traded an average of 861.50K shares per day and 673940 over the past ten days. A total of 72.19M shares are outstanding, with a floating share count of 58.42M. Insiders hold about 19.07% of the company’s shares, while institutions hold 19.37% stake in the company. Shares short for GUTS as of 1755216000 were 2404452 with a Short Ratio of 2.79, compared to 1752537600 on 1889593. Therefore, it implies a Short% of Shares Outstanding of 2404452 and a Short% of Float of 5.19.
Earnings Estimates
A detailed examination of Fractyl Health Inc (GUTS) is currently in progress, with 4.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.14 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$1.3 and -$1.67 for the fiscal current year, implying an average EPS of -$1.52. EPS for the following year is -$1.18, with 4.0 analysts recommending between -$0.99 and -$1.38.
